Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 144

1.

Moving Away from Ritonavir, Abacavir, Tenofovir, and Efavirenz (RATE) - Agents That Concern Prescribers and Patients: A Feasibility Study and Call for a Trial.

Achhra AC, Boyd MA, Law MG, Matthews GV, Kelleher AD, Cooper DA.

PLoS One. 2014 Jun 26;9(6):e99530. doi: 10.1371/journal.pone.0099530. eCollection 2014.

PMID:
24968324
[PubMed - in process]
Free PMC Article
2.

Impaired Nef function is associated with early control of HIV-1 viremia.

Kuang XT, Li X, Anmole G, Mwimanzi P, Shahid A, Le AQ, Chong L, Qian H, Miura T, Markle T, Baraki B, Connick E, Daar ES, Jessen H, Kelleher AD, Little S, Markowitz M, Pereyra F, Rosenberg ES, Walker BD, Ueno T, Brumme ZL, Brockman MA.

J Virol. 2014 Jun 25. pii: JVI.01334-14. [Epub ahead of print]

PMID:
24965469
[PubMed - as supplied by publisher]
3.

HIV-specific antibody-dependent phagocytosis matures during HIV infection.

Ana-Sosa-Batiz F, Johnston AP, Liu H, Center RJ, Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Kim JH, Michael NL, Kelleher AD, Stratov I, Kent SJ, Kramski M.

Immunol Cell Biol. 2014 Jun 10. doi: 10.1038/icb.2014.42. [Epub ahead of print]

PMID:
24913323
[PubMed - as supplied by publisher]
4.

NKT cell depletion in humans during early HIV infection.

Fernandez CS, Kelleher AD, Finlayson R, Godfrey DI, Kent SJ.

Immunol Cell Biol. 2014 Apr 29. doi: 10.1038/icb.2014.25. [Epub ahead of print]

PMID:
24777308
[PubMed - as supplied by publisher]
5.

Human antigen-specific CD4(+) CD25(+) CD134(+) CD39(+) T cells are enriched for regulatory T cells and comprise a substantial proportion of recall responses.

Seddiki N, Cook L, Hsu DC, Phetsouphanh C, Brown K, Xu Y, Kerr SJ, Cooper DA, Munier CM, Pett S, Ananworanich J, Zaunders J, Kelleher AD.

Eur J Immunol. 2014 Jun;44(6):1644-61. doi: 10.1002/eji.201344102. Epub 2014 Apr 29.

PMID:
24752698
[PubMed - in process]
6.

HLA alleles association with changes in bone mineral density in HIV-1-infected adults changing treatment to tenofovir-emtricitabine or abacavir-lamivudine.

Haskelberg H, Cordery DV, Amin J, Kelleher AD, Cooper DA, Emery S; STEAL Study Group.

PLoS One. 2014 Mar 28;9(3):e93333. doi: 10.1371/journal.pone.0093333. eCollection 2014.

PMID:
24681993
[PubMed - in process]
Free PMC Article
7.

Ratios of effector to central memory antigen-specific CD4(+) T cells vary with antigen exposure in HIV+ patients.

Phetsouphanh C, Xu Y, Bailey M, Pett S, Zaunders J, Seddiki N, Kelleher AD.

Immunol Cell Biol. 2014 Apr;92(4):384-8. doi: 10.1038/icb.2013.101. Epub 2014 Feb 4.

PMID:
24492798
[PubMed - in process]
8.

HIV DNA subspecies persist in both activated and resting memory CD4+ T cells during antiretroviral therapy.

Murray JM, Zaunders JJ, McBride KL, Xu Y, Bailey M, Suzuki K, Cooper DA, Emery S, Kelleher AD, Koelsch KK; PINT Study Team.

J Virol. 2014 Mar;88(6):3516-26. doi: 10.1128/JVI.03331-13. Epub 2014 Jan 8.

PMID:
24403590
[PubMed - indexed for MEDLINE]
9.

Incomplete restoration of Mycobacterium tuberculosis-specific-CD4 T cell responses despite antiretroviral therapy.

Hsu DC, Kerr SJ, Thongpaeng P, Iampornsin T, Pett SL, Zaunders JJ, Avihingsanon A, Ubolyam S, Ananworanich J, Kelleher AD, Cooper DA.

J Infect. 2014 Apr;68(4):344-54. doi: 10.1016/j.jinf.2013.11.016. Epub 2013 Dec 8.

PMID:
24325926
[PubMed - in process]
10.

Promoter Targeting shRNA Suppresses HIV-1 Infection In vivo Through Transcriptional Gene Silencing.

Suzuki K, Hattori S, Marks K, Ahlenstiel C, Maeda Y, Ishida T, Millington M, Boyd M, Symonds G, Cooper DA, Okada S, Kelleher AD.

Mol Ther Nucleic Acids. 2013 Dec 3;2:e137. doi: 10.1038/mtna.2013.64.

PMID:
24301868
[PubMed]
Free PMC Article
11.

Temporal effect of HLA-B*57 on viral control during primary HIV-1 infection.

Vaidya SA, Streeck H, Beckwith N, Ghebremichael M, Pereyra F, Kwon DS, Addo MM, Rychert J, Routy JP, Jessen H, Kelleher AD, Hecht F, Sekaly RP, Carrington M, Walker BD, Allen TM, Rosenberg ES, Altfeld M.

Retrovirology. 2013 Nov 18;10:139. doi: 10.1186/1742-4690-10-139.

PMID:
24245727
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Reply to "Issues on results of the external quality assessment for proviral DNA testing of HIV-1 Tropism in the Maraviroc Switch collaborative study".

Tu E, Swenson LC, Land S, Pett S, Emery S, Marks K, Kelleher AD, Kaye S, Kaiser R, Schuelter E, Harrigan R; MARCH Laboratory Group and the MARCH Study Group.

J Clin Microbiol. 2013 Dec;51(12):4287. doi: 10.1128/JCM.02207-13. No abstract available.

PMID:
24243995
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Restoration of CMV-specific-CD4 T cells with ART occurs early and is greater in those with more advanced immunodeficiency.

Hsu DC, Kerr SJ, Iampornsin T, Pett SL, Avihingsanon A, Thongpaeng P, Zaunders JJ, Ubolyam S, Ananworanich J, Kelleher AD, Cooper DA.

PLoS One. 2013 Oct 10;8(10):e77479. doi: 10.1371/journal.pone.0077479. eCollection 2013.

PMID:
24130889
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Characterization of transcription factor phenotypes within antigen-specific CD4+ T cells using qualitative multiplex single-cell RT-PCR.

Phetsouphanh C, Xu Y, Amin J, Seddiki N, Procopio F, Sekaly RP, Zaunders JJ, Kelleher AD.

PLoS One. 2013 Oct 4;8(10):e74946. doi: 10.1371/journal.pone.0074946. eCollection 2013.

PMID:
24124462
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Anal intraepithelial neoplasia and squamous cell carcinoma in HIV-infected adults.

Tong WW, Hillman RJ, Kelleher AD, Grulich AE, Carr A.

HIV Med. 2014 Feb;15(2):65-76. doi: 10.1111/hiv.12080. Epub 2013 Sep 6.

PMID:
24007498
[PubMed - in process]
16.

The majority of HIV type 1 DNA in circulating CD4+ T lymphocytes is present in non-gut-homing resting memory CD4+ T cells.

McBride K, Xu Y, Bailey M, Seddiki N, Suzuki K, Murray JM, Gao Y, Yan C, Cooper DA, Kelleher AD, Koelsch KK, Zaunders J.

AIDS Res Hum Retroviruses. 2013 Oct;29(10):1330-9. doi: 10.1089/AID.2012.0351.

PMID:
23971972
[PubMed - indexed for MEDLINE]
17.

Short communication: HIV blips while on antiretroviral therapy can indicate consistently detectable viral levels due to assay underreporting.

Murray JM, Zaunders JJ, Koelsch KK, Natarajan V, Badralmaa Y, McBride K, Carrera A, Cooper DA, Emery S, Kelleher AD.

AIDS Res Hum Retroviruses. 2013 Dec;29(12):1621-5. doi: 10.1089/AID.2013.0132. Epub 2013 Aug 9.

PMID:
23844947
[PubMed - indexed for MEDLINE]
18.

miRNAs and HIV: unforeseen determinants of host-pathogen interaction.

Swaminathan S, Murray DD, Kelleher AD.

Immunol Rev. 2013 Jul;254(1):265-80. doi: 10.1111/imr.12077. Review.

PMID:
23772625
[PubMed - indexed for MEDLINE]
19.

The role of T cell immunity in HIV-1 infection.

Munier CM, Kelleher AD, Kent SJ, De Rose R.

Curr Opin Virol. 2013 Aug;3(4):438-46. doi: 10.1016/j.coviro.2013.05.009. Epub 2013 Jun 6. Review.

PMID:
23747036
[PubMed - indexed for MEDLINE]
20.

Serial study of lymph node cell subsets using fine needle aspiration in pigtail macaques.

Xu Y, Fernandez C, Alcantara S, Bailey M, De Rose R, Kelleher AD, Zaunders J, Kent SJ.

J Immunol Methods. 2013 Aug 30;394(1-2):73-83. doi: 10.1016/j.jim.2013.05.005. Epub 2013 May 20.

PMID:
23702165
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk